SEC Form 4
Tandem Diabetes Care, Inc. (TNDM) insider trading
In the 12 months to Nov 17, 2026, 2 TNDM insiders reported open-market sales of $36.9K across 3 filings; no open-market purchases were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $36.9K
- 3 filings · 2 insiders
- Open-market purchases
- $0
- 0 filings
- Pre-arranged sales (10b5-1)
- 2 of 3
- $32.6K of $36.9K sold (88%)
Who traded TNDM, and when
- Sale
- Sale, pre-arranged (10b5-1)
TNDM daily close from Nov 17, 2025 to Nov 16, 2026, between $12.82 and $28.26, last $18.48. 3 sale and 0 purchase filings by 2 insiders, marked at their filing dates. Christopher J. Twomey, Director: sold $32.6K across 1 filing, first filed Oct 29, 2026, last Oct 29, 2026. Mark David Novara, EVP & CHIEF COMMERCIAL OFFICER: sold $4.4K across 2 filings, first filed Mar 9, 2026, last Mar 18, 2026.
Largest mark · tap a row for others
Christopher J. Twomey · Director
Sale $32,555
1,700 shares at $19.15 avg
Filed Oct 29, 2026 · traded Oct 27
Pre-arranged (10b5-1) · close on filing date $19.79
Christopher J. Twomey · Director
Director
$32.6K soldMark David Novara · EVP & CHIEF COMMERCIAL OFFICER
EVP & CHIEF COMMERCIAL OFFICER
$4.4K soldOpen-market trades
3 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Christopher J. Twomey | Director | $32.6K | — | 1 | 100% of sales | |
| Mark David Novara | EVP & CHIEF COMMERCIAL OFFICER | $4.4K | — | 2 | 1% of sales |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Christopher J. Twomey Director | SalePre-arranged (10b5-1) | 1,700 | $19.15 | $32.6K | 24,434 | |
traded | Mark David Novara EVP & CHIEF COMMERCIAL OFFICER | Sale | 187 | $23.05 | $4.3K | 37,656 | |
traded | Mark David Novara EVP & CHIEF COMMERCIAL OFFICER | SalePre-arranged (10b5-1) | 2 | $22.81 | $46 | 35,969 |
GET /stocks/filings/vX/form-4?tickers=TNDM&filing_date.gte=2025-11-17&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"TNDM"
],
"issuer_cik": "0001438133",
"owner_cik": "0001238935",
"accession_number": "0001438133-26-000136",
"form_type": "4",
"filing_date": "2026-10-29",
"period_of_report": "2026-10-27",
"issuer_name": "TANDEM DIABETES CARE INC",
"issuer_trading_symbol": "TNDM",
"owner_name": "TWOMEY CHRISTOPHER J",
"is_director": true,
"is_officer": false,
"is_ten_percent_owner": false,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": true,
"transaction_date": "2026-10-27",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 1700,
"transaction_price_per_share": 19.15,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 24434,
"transaction_value": 32554.999999999996,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F2",
"description": "The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2026."
}
]
},
{
"tickers": [
"TNDM"
],
"issuer_cik": "0001438133",
"owner_cik": "0002000342",
"accession_number": "0001438133-26-000023",
"form_type": "4",
"filing_date": "2026-03-18",
"period_of_report": "2026-03-16",
"issuer_name": "TANDEM DIABETES CARE INC",
"issuer_trading_symbol": "TNDM",
"owner_name": "Novara Mark David",
"is_director": false,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "EVP & CHIEF COMMERCIAL OFFICER",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-03-17",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 187,
"transaction_price_per_share": 23.05,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 37656,
"transaction_value": 4310.35,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F2",
"description": "The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2025."
}
]
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 162 records
- Option exercises78 records
- Tax withholding69 records
- Grants and awards11 records
- Gifts2 records
- Other2 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Pre-arranged (10b5-1)
- The insider marked the filing as made under a trading plan set up in advance (SEC Rule 10b5-1). The mark covers the whole filing, and an unmarked filing may still be under a plan.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Frequently asked questions
Has Tandem Diabetes Care, Inc.'s CEO sold stock?
No. John F. Sheridan (CEO) made no open-market sales filed as CEO in the last 12 months.
How current is TNDM’s insider data?
These are TNDM Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track TNDM insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for TNDM every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.